Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health
Ashil Koranne presented a poster at the 2024 MDA Clinical & Scientific Conference highlighting Juvena Therapeutics’ promising preclinical development of JUV-161, a novel fusion protein for treating Myotonic Dystrophy Type 1.
Congratulations to our outstanding ML Engineer, Tejaswini Ganapathi for presenting a poster based on her AI research at Juvena entitled “Prediction of transcriptomic response to perturbagens in unobserved cell lines and cell states” at the ML Drug Discovery Symposium at Broad Institute of MIT and Harvard on October 27, 2023. We presented our exciting development of a generalized machine learning system that predicts biological effects such as gene expression changes on cells.
Juvena’s CSO, Dr. Jeremy O’Connell, and VP Dr. Mo Tabrizi attend and present, both through oral presentation and poster, our DM1 lead program at the annual Myotonic Dystrophy Foundation Conference which we are proud to sponsor
Our Director of Discovery and Platform, Dr. Thach Mai and CSO Dr. Jeremy O’Connell share more about Juvena’s discovery platform and approach to identifying and developing a regenerative biologics for promoting lung epithelium re-growth for the treatment of idiopathic pulmonary fibrosis at the IPF 2023 Annual summit.
The Juvena team made a big splash at the 5th Age-Related Disease Therapeutics Summit in San Francisco! CEO, Dr. Hanadie Yousef gave a well received talk on mapping secreted proteins to unmet medical needs, as well as moderating the session of impressive speakers focused on biomarkers for age-related and chronic diseases. Juvena’s VP of Data Science, Dr. Eddie Moler co-led a pre-conference workshop on exploring the promise of AI-Powered drug discovery for the progression of age-related therapies, while Computational Biologist, Dr. Rohit Jadhav presented a poster on Juvena’s proteomics platform for mining the secretomes of stem cells.
Co-founders, Dr. Hanadie Yousef and Dr. Jeremy O’Connell were invited speakers at the 2nd Annual Longevity Conference in SF. While Yousef gave an oral presentation, O’Connell presented a poster about Juvena’s quantitative proteomics approach for mining the secretome of human pluripotent stem cells.
